Overview
Work History
Education
Skills
Accomplishments
Timeline
Generic

Uksha Saini

Pearland

Overview

15
15
years of professional experience

Work History

Senior Scientist

Fannin
08.2022 - Current
  • Independently design, execute, troubleshoot and evaluate experiments and scientific tasks with a high level of scientific rigor and curiosity
  • Coordinate research activities among departments and institutions in multi-departmental and multi-institutional projects
  • Assist in identifying possible sources of funding support
  • Design and develop in vivo studies on tumor mouse models to characterize stromal and immune cells phenotype, function and interaction to accelerate projects in pre-clinical and clinical development


  • Mouse models of ALL, lung cancer, Multiple Sclerosis, Obesity, Neuroinflammation and testing immunotherapies as well as DNA based therapeutics
  • PK/PD studies in rats
  • Developing and troubleshooting cell-based assays like ADCC, ADCP, CDC
  • Develop, maintain, and train colleagues on both established and novel in vitro, in vivo/ex vivo analyses of immune and tumor cell populations
  • Make strong contributions to research team short- and long-term scientific strategies, including incorporation of emerging clinical trends
  • Effectively communicate scientific results and strategies at both internal and external venues
  • Effectively collaborate with multi-disciplinary teams to proactively solve problems and advance research program
  • Ensure data generated is communicated in a concise, easy to understand manner to the appropriate teams and stakeholders
  • Grant writing , Managing and updating the IACUC protocols and trainings of the team members

Research Scientist

Nationwide Children's Hospital
08.2018 - 07.2022

At Nationwide Children’s Hospital, I worked on mouse nervous system tumor models (CNS and MPNST) to tease out the pre-clinical efficacy and safety studies using oncolytic virus and exosome-based therapies as well as demonstration of the mechanism of action of gene therapies through in vitro and in vivo pre-clinical proof of concept studies. I worked on designing and validation of the virus-targeting constructs and then generating and molecular confirmation of the oncolytic virus first in vitro and then in vivo on mouse models (both flank and intracranial). The effects are analyzed by immunophenotypic analyses of the lymphoid and myeloid infiltrates by flow cytometry, Cytof or single cell sequencing. Another aspect of my research has been using exosomes as target gene delivery vehicles (packed with cytokines or drugs or AAV) on the mouse models and validating the effects. The studies have resulted in the following patent:

“Extracellular Vesicle (EVs) for Therapeutic Delivery to Tumors Delivery”, Provisional patent applied for “Loading Extracellular Vesicles with cargo”., NCH Ref #2020-100 “TARGET-ED”

Postdoctoral Scientist

OSUMC
04.2013 - 08.2018

My primary research work at the Ohio State University focused on the molecular and biochemical behavior of drug resistance in ovarian clear cell cancer and ovarian cancer therapeutics. I have been working in the field of cancer research for more than 8 years. My research interest was directed towards: i) Dissecting the role of STAT3 and targeting ovarian cancer; ii) the role of TMEM205 in imparting drug resistance to ovarian clear cell cancer and iii) the use and mechanism of action of novel synthetic curcumin analog compounds for ovarian cancer therapy; iv) to elucidate the role of STAT3 and PIAS3 in the initiation and early tumorigenesis of HGSC v) utilizing oHSV virotherapy and deciphering the host-pathogen mechanisms involved in the same vi) analyzing the Role of STAT3 activation in the fallopian tube and development of ovarian HGSC and TMEM205 mediated chemoresistance in human ovarian clear cell carcinoma.

Postdoctoral Researcher

OSUMC
04.2011 - 07.2013

Mesenchymal Stem Cell based approaches to address ischemia/reperfusion and hypoxia associated cardiac damage

I also worked on various molecular, biochemical and physiological behavioral aspects of stem cells in order to make them more viable and effective in ischemia/reperfusion and hypoxia conditions during cardiac arrest. Another aspect of the work involved studying the molecular and cell signaling and crosstalk of human Lamin A/C gene and mutant lamin A/C genes at genomic and proteomic levels in congenital cardiac defect patients.

Postdoctoral Researcher

BGSU
08.2008 - 12.2010

Developing a tunable light switch using Anabaena Sensory Rhodopsin (ASR)

The far-reaching goal of this research was to elucidate the function and molecular basis of interactions between the sensory rhodopsin form Anabaena (ASR) and its transducer, so as to decipher the biological function of this relatively less known protein. Site directed color tuning mutants were also developed which showed specific spectral features and have a potential to be developed into molecular switches. Since the above proteins resemble the human rhodopsin to a large extent, the far-reaching impact of this study is to help eye diseases related to partial or complete sight loss.

Education

Bachelor of Science - Biology

Himachal Pradesh University
05.1999

MS - Plant Physiology

HPKVV
Palampur, India
08.2001

Ph.D. - Biotechnology

IHBT
Palampur, India
01.2007

Skills

Technical Skills

  • Very well versed in mouse survival surgeries , in vivo implanting tumors into mice (orthotopic in brain using stereotactic frame, ovary by exposing ovaries, and in flank), intratumoral subcutaneous and intraperitoneal injections, intratibial, drug dosing, perform caliper measurements of tumors, processing the tumors for immunophenotyping,
  • In vitro assays, ex vivo, syngeneic and PDX in vivo tumor models based evaluation of efficacy of oncolytic virus (HSV and AAV) candidates and/or other therapeutics in brain and peripheral nerve sheath tumors and ovarian cancer models
  • Successful tracking and delivery of EVs in mouse tumor models
  • Computational biology skills like RNAseq, single cell seq and CyTOF, analyses using Cytobank, Omiq, Loupe
  • Hands on survival surgeries experience for mouse brain tumor (orthotopic and flank based) and ovarian cancer syngeneic as well as PDX models
  • Experienced in designing and conducting experiments using Multicolor flow cytometry (14 color) for lymphoid and myeloid immune cell phenotyping, routine and biomarker testing, using Attune Nxt Flow Cytometer, data collection and analyses using Flowjo and Attune Software and plotting histograms using PRISM
  • Phase contrast, fluorescence and Confocal microscopy, IVIS imaging, Sony flow sorter, Cytation 5
  • Expertise in molecular and cellular biology of immune cells, design and performing functional assays,
  • Expertise in studies on DNA/RNA/protein expression (qPCR, RT-qPCR, Western Blot, Southern blot and ELISA) and cell biology
  • Isolating and culturing macrophages and NK cells from PBMCs and functional assays like ADCC, ADCP, CDC
  • Hands-on expertise in T-cell functional characterization assays as in vitro cytotoxicity, proliferation, cytokine measurement
  • CTL killing assays, Peptide pulsing and tetramer staining
  • Immunohistochemistry, histology, In situ hybridisation
  • Cell based assays, luciferase and enzymatic assays
  • 7 years of Exosome isolation from various primary and immortalized cell lines, human CSF, blood; mouse blood
  • Characterization of exosomes using nanosight, immunoblotting and nano-flow cytometer
  • Loading the Extracellular Vesicles (EVs/exosomes) by active and passive methods with cytokines, oligonucleotides, AAV, HSV, chemokines or chemotherapeutic agents
  • Biomarker assays on exosomes
  • Nanosight
  • Genetic modifications/gene therapy for gene inhibition or augmentation in cells including vector design, cloning and transfections, electroporation, lentivirus mediated transformation, shRNA and SSO mediated manipulations, site directed mutagenesis
  • Knowledge of Fc Receptor signaling, Antigen presenting cell biology, MHC-I/MHC-ll peptide presentation in APC, immune checkpoint signaling
  • Hands on isolation, characterisation, culturing and functional assays of primary immune cells (T cells, NK cells) from tumors and spleens as well as mesenchymal stem cells (MSCs) from femurs, primary cell culture from mouse muscles and human patient ascites and using enrichment kits for cell subtype isolation
  • Demonstrated lab technical knowledge, document organization, presentation and writing skills
  • Proficient in standard scientific software used for data analysis (Microsoft Excel, Prism, R) as well as Microsoft Word and PowerPoint

Leadership skills

Lead, interpret, troubleshoot, supervise and present multiple cross-functional research drug discovery projects ranging from small molecule inhibitors, oncolytic viruses and exosome mediated cargo delivery

  • 10 years of experience in overseeing, managing and directing research lab activities, including experimental planning, processing, troubleshooting, analysis and supervising, training, mentoring and managing other lab members, validation and implementation of new procedures and working with vendors, write and follow Standard Operating Procedures, effective oral and written presentation skills, maintaining adequate lab inventory
  • Efficiently communicate and collaborate within and across multidisciplinary research and clinical teams as well as amongst institutions and organizations and build consensus
  • Talented in guiding all functions related to research studies, analysis, reviewing quality control, reporting and writing grants and manuscripts, writing, revising and managing IACUC and IRB protocols in a timely, accurate and efficient manner
  • Accurate maintenance of records of procedures in clear, concise, understandable and reproducible manner
  • Troubleshooting to identify and correct the roadblocks related to sample preparation and accurate communication of outcomes
  • Detail oriented, Critical thinker, problem solver and detail oriented, ability to meet aggressive deadlines
  • Work extremely well under pressure and drive projects that impact critical timelines

Accomplishments


  • I am a contributor on 2 patents and authored 49 peer-reviewed publications/reviews/abstracts


  • I have been successfully executing and managing multiple research projects for the past 10+ years, and my goal is to contribute towards development and commercialization of safe therapies


  • Awards / Honors
  • Our fallopian tube and exosome research works were selected for highlight section oral/poster presentation in Society of Gynecologic Oncology annual meeting (SGO-2016 March), entitled- STAT3/PIAS3 as “early signature” gene pathways in the development of ovarian high grade serous carcinoma from the fallopian tube Uksha Saini, Kristin Bixel, John Wallbillich, Maria Riley, John M Fowler, Ross Wanner; Jenny Lester, Beth Karlan, Paul Goodfellow, Adrian Suarez, David Cohn, Karuppaiyah Selvendiran (SGO-2016 March- Abstract #5321))
  • Hypoxia-facilitated exosomal release from ovarian cancer cells is regulated by STAT3 and is associated with increased metastatic tumor burden (SGO Abstract #6664) Kalpana Deepa Priya Dorayappan, John Wallbillich, Uksha Saini, Kristin Bixel, Maria Riley, Roman Zingarelli, Ross Wanner; Paul Goodfellow, David Cohn, Karuppaiyah Selvendiran
  • My abstract entitled “Targeting TMEM205 mechanotransduction pathway using oncolytic virus therapy in ovarian clear cell carcinoma (OCCC)” was selected as one of the 17 finalists

Timeline

Senior Scientist

Fannin
08.2022 - Current

Research Scientist

Nationwide Children's Hospital
08.2018 - 07.2022

Postdoctoral Scientist

OSUMC
04.2013 - 08.2018

Postdoctoral Researcher

OSUMC
04.2011 - 07.2013

Postdoctoral Researcher

BGSU
08.2008 - 12.2010

Bachelor of Science - Biology

Himachal Pradesh University

MS - Plant Physiology

HPKVV

Ph.D. - Biotechnology

IHBT
Uksha Saini